Skip to main content

Table 11 Cost-effectiveness analysis (CEA) outcomes for mixed wound types (n = 3)

From: A systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound types

CEA (Original year of values)

Treatment vs. Comparator

ICER summary/estimate [2013 US$]

Unit of effectiveness

Incremental cost [2013 US$]

Incremental effectiveness

Bale 1998 (1994) [78]

Hydrocellular (Allevyn) dressing vs. hydrocolloid (Granuflex) dressing

26

Additional wound healed

3

0.13

Terry 2009 (2008) [79]

Telemedicine plus WCS consults vs. WCS consults only

Dominateda

Additional wound healed

2,085

−0.249

Vu 2007 (2000) [80]

Multidisciplinary wound care team vs. UC

Dominantb

Additional wound healed

−346

0.092

  1. ICER, Incremental cost-effectiveness ratio; UC, Usual care; US$, United States dollars; WCS, Wound care specialist.
  2. a“Disproportionate distribution, by chance, in group A [telemedicine plus WCS consults] of large non-healing surgical wounds and large, numerous pressure ulcers”.
  3. bDenotes the higher quality study (Drummond score ≥8).